ANXA2 and hepatocellular carcinoma: Mesenchymal stem cells enhance the malignant characteristics of HCC cells, partly through the lncRNA-MUF interaction with ANXA2, which activates Wnt/β-catenin signaling and promotes epithelial–mesenchymal transition (38).